News Focus
News Focus
icon url

Vegas8ball

08/13/21 1:43 PM

#350413 RE: rafunrafun #350412

Thanks RAF. I’ve been taking Vascepa for the past 16 months. Went to CVS yesterday, and once again, had to ask them to refill my Script because they were selling me generic Hikma. Pharmacist told me that the computer system automatically changes the Script to generic; even though my account specifically requests BRAND. Craziness. No wonder Hikma is gaining market share on Refills (as per KM in our recent Shareholder broadcast).
icon url

Whalatane

08/13/21 1:52 PM

#350415 RE: rafunrafun #350412

Raf. thx for the script data
Kiwi
icon url

zmanindc

08/13/21 2:03 PM

#350417 RE: rafunrafun #350412

Generic lovazza is what is eating into our growth and I am sad to say that two family members in NY were told by their cardiologists that V is a trig drug. One family member was told their trigs were fine so they left without a script. The other was given a script for GL and he claims it’s too hard on his stomach and stopped taking it altogether. I think these scripts are getting swapped for GL and I think GL has lots of script attrition because it’s on on your stomach. I blame the Amarin sales and marketing team. I gave my relatives the information to hand to their cardiologist for a real V script. They will let me know what happens on their next appointment.
icon url

Anilkhera

08/13/21 2:13 PM

#350421 RE: rafunrafun #350412

Thank you so much Raf for scripts update!!
icon url

rafunrafun

08/20/21 10:58 AM

#351478 RE: rafunrafun #350412

Scripts for week ending August 13, 2021

Overall drug TRx are flat

Vascepa
TRx 81,381; -2.4% (-2,008) w/w; -9.3% y/y
NRx 35,844; -2.8% (-1,050) w/w; -13.2% y/y
Ref 45,537; -2.1% (-959) w/w; -6.0% y/y


Lovaza (Generic & Brand)
TRx 62,518; -1.1% (-670) w/w; +0.4% y/y
NRx 30,051; +0.3% (+92) w/w;
-2.0% y/y
Ref 32,467; -2.3% (-762) w/w;
+2.6% y/y

Generic Vascepa
TRx 16,108; +6.5% (+985) w/w; As % of total V: 16.5%
NRx 9,056; +6.9% (+583) w/w; As % of total V: 20.2%
Ref 7,052; +6.0% (+402) w/w; As % of total V: 13.4%


Generic Vascepa by Manufacturer
Hikma TRx 12,063 (+546); Generic share 74.9%; Total V share 12.4%
Reddy TRx 4,045 (+439); Generic share 25.1%; Total V share 4.1%